At Avatar Behavioral Health, we offer Esketamine (Spravato®) treatment in New Jersey for individuals experiencing treatment-resistant depression or severe depressive symptoms that have not improved with traditional medications. Spravato therapy is an FDA-approved treatment administered under medical supervision, providing an innovative option for individuals seeking new approaches to depression care.
Schedule a Consultation Today
Esketamine, marketed as Spravato®, is an FDA-approved prescription nasal spray used alongside an oral antidepressant to treat treatment-resistant depression (TRD) and certain cases of major depressive disorder with suicidal thoughts or behaviors.
Unlike traditional antidepressants, which primarily affect serotonin pathways, Esketamine targets the brain’s glutamate system, which plays a critical role in mood regulation and neural connectivity.
At Avatar Behavioral Health, Spravato treatment is delivered in a certified clinical setting under the FDA Risk Evaluation and Mitigation Strategy (REMS) program, ensuring patient safety and proper monitoring.
Esketamine therapy may be recommended for individuals who:
Our clinicians conduct a comprehensive psychiatric evaluation to determine whether Spravato therapy is appropriate for each patient.
A licensed clinician evaluates your symptoms, treatment history, and overall mental health to determine eligibility for Esketamine therapy.
Spravato is administered as a nasal spray under clinical supervision at our treatment center.
Patients remain at the clinic for approximately two hours of observation following treatment to ensure safety.
Esketamine therapy is typically delivered on a structured schedule as part of a broader mental health treatment plan.
Spravato therapy may be recommended for individuals experiencing:
Our clinical team works closely with each patient to develop a personalized treatment strategy.
Traditional antidepressants typically target serotonin and dopamine pathways. Esketamine works differently by influencing the glutamate system, which is involved in synaptic communication in the brain. This alternative mechanism may help individuals who have not responded to conventional treatments.
Choosing the right Spravato treatment center in New Jersey is important for both safety and treatment effectiveness.
Avatar Behavioral Health provides:
Our goal is to provide advanced mental health treatment options while prioritizing patient safety and compassionate care.
During an Esketamine treatment appointment:
Because Esketamine may temporarily affect alertness, patients must arrange transportation following treatment.
Many insurance providers cover Esketamine therapy for treatment-resistant depression when medical criteria are met.
Avatar Behavioral Health is committed to providing evidence-based mental health care in New Jersey through personalized treatment and compassionate support. Patients benefit from:
